ASX:API Australian Pharmaceutical Industries (API) Stock Price, News & Analysis → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free API Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume453,647 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield2.29%Price TargetN/A Stock AnalysisStock Analysis Get Australian Pharmaceutical Industries alerts: Email Address Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide About Australian Pharmaceutical Industries Stock (ASX:API)Australian Pharmaceutical Industries Limited engages in the wholesale distribution of pharmaceutical, medical, health, beauty, and lifestyle products to pharmacies primarily in Australia. It also retails health and beauty products to consumers through a network of Priceline and Priceline Pharmacy franchise stores, and company owned Priceline stores in Australia; sells beauty products through Clear Skincare network of clinics in Australia and New Zealand; and manufactures and distributes pharmaceutical and toiletry goods to New Zealand, Australian, and Asian markets, as well as provides cosmetic products and non-invasive aesthetic beauty services. The company was founded in 1910 and is based in Camberwell, Australia.Read More Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide API Stock News HeadlinesApril 22, 2024 | msn.comSri Lankan pharmaceutical industry to reduce 30% pharma imports by 2030March 29, 2024 | au.finance.yahoo.comChemist Warehouse speaks out over fears Sigma Healthcare merger will raise pricesApril 29, 2024 | Priority Gold (Ad)Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.March 28, 2024 | msn.comAfrican Pharmaceutical Technology Foundation and Pharmaceutical Institute Partner to Strengthen Nigeria's Pharmaceutical and Vaccine Manufacturing Capacity [announcement]March 18, 2024 | sg.finance.yahoo.comCambrex Nears Completion of 5-year, $100-Million-Dollar Investment Plan, One Year Ahead of ScheduleFebruary 27, 2024 | msn.comReal Housewives of Dubai's Caroline Stanbury and her soccer star husband Sergio Carrallo are left furious after booking the 'best seats on the plane' - only to find themselves ...February 26, 2024 | dailymail.co.ukBeyonce's uncle dead at 77: Megastar's mom Tina Knowles reveals Air Force veteran older brother Butch has passed awayFebruary 23, 2024 | bizjournals.comLocal innovation nonprofit focused on drug manufacturing inks pact with key industry groupApril 29, 2024 | Priority Gold (Ad)Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.February 5, 2024 | finance.yahoo.comGlobal Blister Packaging Market to Reach Value of USD 42.71 Billion by 2030 | Skyquest TechnologyFebruary 5, 2024 | sg.news.yahoo.comIndia's Alembic Pharma beats Q3 profit view on strong domestic, US salesJanuary 16, 2024 | msn.comContinuous Flow Chemistry for Scalable Drug SynthesisJanuary 6, 2024 | nasdaq.comFebruary 23rd Options Now Available For Teva Pharmaceutical IndustriesDecember 15, 2023 | finance.yahoo.comBiological Drug API Manufacturing Services market is projected to grow at a CAGR of 11.6% by 2033: VisiongainDecember 11, 2023 | msn.comWhat does the Chemist Warehouse merger with Sigma Healthcare mean for the pharmacy giant?December 8, 2023 | bbc.comBritishvolt bought by Australian firm Recharge IndustriesNovember 28, 2023 | msn.comKronox Lab Sciences files draft papers with Sebi for IPONovember 8, 2023 | msn.comCanada To Australia: New MDMA & Psilocybin Shipment On Its Way For Legal Therapeutic MarketNovember 7, 2023 | finance.yahoo.comPharmAla Completes Historic First Shipment of MDMA and Psilocybin to CortexaNovember 2, 2023 | tmcnet.comPharmaceutical and Food Industries Drive Demand for Active and Intelligent Nano-Enabled Packaging SolutionsOctober 24, 2023 | tmcnet.comGluware Takes Center Stage at ONUG Fall 2023 in Keynote with World Wide Technology that Highlights the Power of Pre-Built Network AutomationSeptember 27, 2023 | msn.comSouth Waikato’s Cannasouth exports first shipment of cannabis API to AustraliaAugust 24, 2023 | au.investing.comThe morning catch up: ASX to drop as September losses loomAugust 24, 2023 | foxnews.comAustralia's wine industry grapples with oversupply issues amidst Chinese tariffs and pandemic disruptionsAugust 10, 2023 | fool.com.auWesfarmers share price climbs amid ACCC green lightJuly 31, 2023 | finance.yahoo.comThe Global Plant-based API Market size is expected to reach $42.6 billion by 2030, rising at a market growth of 5.8% CAGR during the forecast periodJuly 6, 2023 | afr.comWhy leaders with big egos worry Rob Scott the mostSee More Headlines Receive API Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Australian Pharmaceutical Industries and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/17/2019Today4/29/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorBusiness Services Industry Medical Equipment Wholesale Sub-IndustryN/A Current SymbolASX:API CUSIPN/A CIKN/A Webwww.api.net.au Phone+61-3-88553000FaxN/AEmployees2,020Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth1.28Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio71.32 Current Ratio1.20 Quick Ratio0.77 Sales & Book Value Annual Sales$4.00 billion Price / Sales0.00 Cash FlowN/A Price / Cash Flow8.26 Book ValueA$0.89 per share Price / BookN/AMiscellaneous Outstanding Shares492,656,000Free FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Richard C. Vincent C.P.A.B.Bus, (Accountancy), CPA, MD, CEO & Exec. DirectorMr. Peter MendoChief Financial OfficerMr. Dean MatthewsChief Information OfficerMs. Anne Mustow B.Com.L.L.B., Gen. Counsel & Company Sec.Mr. Stephen ArthursonGen. Mang. of PeopleMr. D. GlanceNSW State Mang.More ExecutivesKey Competitors16421 (MRM.L)LON:MRM21512 (SAT.L)LON:SAT41578029 (BT.L)LON:BT435793 (ACM.L)LON:ACM54323 (GLS.L)LON:GLSView All Competitors API Stock Analysis - Frequently Asked Questions How were Australian Pharmaceutical Industries' earnings last quarter? Australian Pharmaceutical Industries Limited (ASX:API) issued its earnings results on Wednesday, April, 17th. The company reported $0.05 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.05 by $0.00. Is Australian Pharmaceutical Industries a good dividend stock? Australian Pharmaceutical Industries (ASX:API) pays an annual dividend of A$0.04 per share and currently has a dividend yield of 2.29%. The dividend payout ratio is 1,333.33%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for API. What other stocks do shareholders of Australian Pharmaceutical Industries own? Based on aggregate information from My MarketBeat watchlists, some companies that other Australian Pharmaceutical Industries investors own include Capricorn Metals (CMM), Austal (ASB), Mod Resources (MOD), Harvey Norman (HVN), Evolution Mining (EVN) and Downer EDI (DOW). This page (ASX:API) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Australian Pharmaceutical Industries Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
